Healthcare · Active clinical trials

Active clinical trials in Afghanistan in 2026

In 2026, Afghanistan had only 2 units active clinical trial, placing it 109th out of 197 countries. This minimal activity reflects a lack of pharmaceutical infrastructure, political instability, and weak regulatory oversight. Research hubs in Kabul and other major cities rarely participate in international multi-center projects. While the global leader, China, conducts thousands of such studies, even single trials in Afghanistan face severe logistical and ethical hurdles.

Data for 2026 · unit: units
Position

Afghanistan world ranking

#109 / 197

Country position on the scale from last to first place for this indicator.

AF
#109
#197#1
Trend

Change over time

Change in indicator over the available period.

0
1990
1
2000
1
2010
2
2020
1
2025
2
2026

Values — units

Related questions

People also search for

Other pages of the reference by this indicator.

Summary

Frequently asked questions

Active clinical trials in Afghanistan — how much?
Based on 2026 data — 2 units. This is rank #109 out of 197 countries.
What is Afghanistan's rank by Active clinical trials?
Afghanistan ranks #109 out of 197 countries in the world ranking by «Active clinical trials».
How has Active clinical trials changed in Afghanistan?
Over the available period the indicator changed from 0 to 2 units.